Compare Samcro Hyosung Adilestari Tbk. (ACRO) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Samcro Hyosung Adilestari Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Samcro Hyosung Adilestari Tbk. trades at Rp60 (market cap 208.16B, 9.55M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp152 (market cap 556.95B, 60.83M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.7× Samcro Hyosung Adilestari Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (60.83M versus 9.55M). Which is the better fit depends on your goals.
| ACRO | LABS | |
|---|---|---|
Market Cap | 208.16B | 556.95B |
Volume | 9.55M | 60.83M |
Lot | 95.5K | 608.34K |
Turnover | 587.56M | 10.26B |
Average Price | 61.52 | 168.64 |
Value | 587.56M | 10.26B |
Indicative Equilibrium Price | 60 | 152 |
Indicative Equilibrium Volume | 2K | 4.52K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Samcro Hyosung Adilestari Tbk.
PT Samcro Hyosung Adilestari Tbk (The Company) was established on Republic of Indonesia based on Deed of Establishment No. 265 dated July 21, 1989 by Yudo Paripurno, S.H., Notary in Jakarta.
Read more on ACRO →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
